Progyny, Inc.
PGNY
$18.31
$0.693.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 318.40M | 313.35M | 332.87M | 324.04M | 298.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 318.40M | 313.35M | 332.87M | 324.04M | 298.43M |
| Cost of Revenue | 241.52M | 240.51M | 253.90M | 248.24M | 235.00M |
| Gross Profit | 76.88M | 72.84M | 78.97M | 75.80M | 63.43M |
| SG&A Expenses | 53.96M | 51.31M | 54.62M | 51.63M | 47.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 295.48M | 291.82M | 308.52M | 299.87M | 282.64M |
| Operating Income | 22.92M | 21.53M | 24.36M | 24.17M | 15.79M |
| Income Before Tax | 17.85M | 23.96M | 27.08M | 26.54M | 17.66M |
| Income Tax Expenses | 5.37M | 10.10M | 9.97M | 11.48M | 7.13M |
| Earnings from Continuing Operations | 12.49M | 13.86M | 17.11M | 15.06M | 10.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.49M | 13.86M | 17.11M | 15.06M | 10.53M |
| EBIT | 22.92M | 21.53M | 24.36M | 24.17M | 15.79M |
| EBITDA | 24.29M | 22.80M | 25.56M | 25.28M | 16.66M |
| EPS Basic | 0.15 | 0.16 | 0.20 | 0.18 | 0.12 |
| Normalized Basic EPS | 0.19 | 0.17 | 0.20 | 0.19 | 0.13 |
| EPS Diluted | 0.14 | 0.15 | 0.19 | 0.17 | 0.12 |
| Normalized Diluted EPS | 0.18 | 0.17 | 0.19 | 0.19 | 0.12 |
| Average Basic Shares Outstanding | 85.23M | 86.02M | 85.77M | 85.50M | 85.81M |
| Average Diluted Shares Outstanding | 89.46M | 90.23M | 89.64M | 89.31M | 88.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |